| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.17 | 0.6 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |